IZUMO1
Izumo sperm-egg fusion protein 1
Also known as: IZUM1_HUMAN, IZUMO, MGC34799, OBF
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IYV9
- Gene
- IZUMO1
- Ensembl
- ENSG00000182264
- Chromosome
- 19
- Canonical length
- 350 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The sperm-specific protein Izumo, named for a Japanese shrine dedicated to marriage, is essential for sperm-egg plasma membrane binding and fusion (Inoue et al., 2005 [PubMed 15759005]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
350 residues, UniProt reviewed canonical sequence.
>Q8IYV9|IZUMO1
1 MGPHFTLLCA ALAGCLLPAE GCVICDPSVV LALKSLEKDY LPGHLDAKHH KAMMERVENA
61 VKDFQELSLN EDAYMGVVDE ATLQKGSWSL LKDLKRITDS DVKGDLFVKE LFWMLHLQKE
121 TFATYVARFQ KEAYCPNKCG VMLQTLIWCK NCKKEVHACR KSYDCGERNV EVPQMEDMIL
181 DCELNWHQAS EGLTDYSFYR VWGNNTETLV SKGKEATLTK PMVGPEDAGS YRCELGSVNS
241 SPATIINFHV TVLPKMIKEE KPSPNIVTPG EATTESSISL QPLQPEKMLA SRLLGLLICG
301 SLALITGLTF AIFRRRKVID FIKSSLFGLG SGAAEQTQVP KEKATDSRQQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IZUMO1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 18 nTPM
Expression across tissuesHPA
Tissue
- testis: 18 nTPM
- pancreas: 1.6 nTPM
- stomach: 1 nTPM
- lung: 0.8 nTPM
- duodenum: 0.5 nTPM
- epididymis: 0.4 nTPM
Single-cell type
- early spermatids: 188 nCPM
- late spermatids: 147 nCPM
- late primary spermatocytes: 70 nCPM
- parietal cells: 19 nCPM
- retinal ganglion cells: 12 nCPM
- tuft cells: 12 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 1.8 nTPM
- cerebral cortex: 0.9 nTPM
- amygdala: 0.4 nTPM
- pons: 0.4 nTPM
- basal ganglia: 0.3 nTPM
- medulla oblongata: 0.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IZUMO1.
Disease | ImmuneIEDB
Conditions an epitope on IZUMO1 was assayed in.
- infertility B cell
- male infertility B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.17
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.1
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- binding of sperm to zona pellucida
- cell adhesion
- fusion of sperm to egg plasma membrane involved in single fertilization
- sperm-egg recognition
- syncytium formation by plasma membrane fusion
Molecular functions
- identical protein binding
- protein binding involved in heterotypic cell-cell adhesion
- protein homodimerization activity
- signaling receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Immunoglobulin-like fold
- Izumo sperm-egg fusion protein
- Immunoglobulin-like domain superfamily
- Izumo sperm-egg fusion, Ig domain-associated
- Izumo protein, immunoglobulin domain
- Izumo sperm-egg fusion protein 1
- Izumo-like Immunoglobulin domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IZUMO1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IZUMO1 as an antibody target. Whether an autoantibody or antibody against IZUMO1 could matter depends on whether native IZUMO1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IZUMO1 is annotated at the cell surface, where native IZUMO1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label IZUMO1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...